BioWisdom, Asterand Ink Data Syndication Agreement | GenomeWeb

NEW YORK (GenomeWeb News) — BioWisdom will integrate data from Asterand's gene expression profile database with its software under a new data syndication agreement, Asterand said today.

BioWisdom will harmonize with its software the data from Asterand's Target Evaluator database, which consists of quantitative human gene expression profiles that chart the expression of over 2,500 gene transcripts across a panel of 72 human tissues. These profiles are generated using human RNA and an RT-PCR protocol.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.